165 related articles for article (PubMed ID: 28647207)
1. Clinical value of miR-425-5p detection and its association with cell proliferation and apoptosis of gastric cancer.
Zhang Z; Wen M; Guo J; Shi J; Wang Z; Tan B; Zhang G; Zheng X; Zhang A
Pathol Res Pract; 2017 Aug; 213(8):929-937. PubMed ID: 28647207
[TBL] [Abstract][Full Text] [Related]
2. miR-486-5p expression pattern in esophageal squamous cell carcinoma, gastric cancer and its prognostic value.
Ren C; Chen H; Han C; Fu D; Zhou L; Jin G; Wang F; Wang D; Chen Y; Ma L; Zheng X; Han D
Oncotarget; 2016 Mar; 7(13):15840-53. PubMed ID: 26895105
[TBL] [Abstract][Full Text] [Related]
3. Expression and prognostic value of miR-486-5p in patients with gastric adenocarcinoma.
Chen H; Ren C; Han C; Wang D; Chen Y; Fu D
PLoS One; 2015; 10(3):e0119384. PubMed ID: 25793394
[TBL] [Abstract][Full Text] [Related]
4. MicoRNA-425-5p is a potential prognostic biomarker for cervical cancer.
Sun L; Jiang R; Li J; Wang B; Ma C; Lv Y; Mu N
Ann Clin Biochem; 2017 Jan; 54(1):127-133. PubMed ID: 27166306
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-195 inhibits human gastric cancer by directly targeting basic fibroblast growth factor.
Wang J; Li L; Jiang M; Li Y
Clin Transl Oncol; 2017 Nov; 19(11):1320-1328. PubMed ID: 28500362
[TBL] [Abstract][Full Text] [Related]
6. miR-183-5p acts as a potential prognostic biomarker in gastric cancer and regulates cell functions by modulating EEF2.
Li W; Cui X; Qi A; Yan L; Wang T; Li B
Pathol Res Pract; 2019 Nov; 215(11):152636. PubMed ID: 31558304
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of miR-145-5p correlates with poor prognosis in gastric cancer.
Zhang Y; Wen X; Hu XL; Cheng LZ; Yu JY; Wei ZB
Eur Rev Med Pharmacol Sci; 2016 Jul; 20(14):3026-30. PubMed ID: 27460730
[TBL] [Abstract][Full Text] [Related]
8. Identification and functional characterization of microRNAs reveal a potential role in gastric cancer progression.
Li CY; Liang GY; Yao WZ; Sui J; Shen X; Zhang YQ; Peng H; Hong WW; Ye YC; Zhang ZY; Zhang WH; Yin LH; Pu YP
Clin Transl Oncol; 2017 Feb; 19(2):162-172. PubMed ID: 27173517
[TBL] [Abstract][Full Text] [Related]
9. High miR-324-5p expression predicts unfavorable prognosis of gastric cancer and facilitates tumor progression in tumor cells.
Zheng Z; Li J; An J; Feng Y; Wang L
Diagn Pathol; 2021 Jan; 16(1):5. PubMed ID: 33430926
[TBL] [Abstract][Full Text] [Related]
10. Circular RNA_LARP4 inhibits cell proliferation and invasion of gastric cancer by sponging miR-424-5p and regulating LATS1 expression.
Zhang J; Liu H; Hou L; Wang G; Zhang R; Huang Y; Chen X; Zhu J
Mol Cancer; 2017 Sep; 16(1):151. PubMed ID: 28893265
[TBL] [Abstract][Full Text] [Related]
11. Differentially expressed long noncoding RNAs and regulatory mechanism of LINC02407 in human gastric adenocarcinoma.
Zhou LL; Jiao Y; Chen HM; Kang LH; Yang Q; Li J; Guan M; Zhu G; Liu FQ; Wang S; Bai X; Song YQ
World J Gastroenterol; 2019 Oct; 25(39):5973-5990. PubMed ID: 31660034
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of microRNA-23a/b promotes tumor progression and confers poor prognosis in patients with gastric cancer.
Ma G; Dai W; Sang A; Yang X; Gao C
Int J Clin Exp Pathol; 2014; 7(12):8833-40. PubMed ID: 25674252
[TBL] [Abstract][Full Text] [Related]
13. miR-99a-5p as Possible Diagnostic and Prognostic Marker in Patients With Gastric Cancer.
Saito R; Maruyama S; Kawaguchi Y; Akaike H; Shimizu H; Furuya S; Kawaida H; Ichikawa D
J Surg Res; 2020 Jun; 250():193-199. PubMed ID: 32078828
[TBL] [Abstract][Full Text] [Related]
14. MiR 21-5p as a predictor of recurrence in young gastric cancer patients.
Park SK; Park YS; Ahn JY; Do EJ; Kim D; Kim JE; Jung K; Byeon JS; Ye BD; Yang DH; Park SH; Hwang SW; Jung HY; Myung SJ
J Gastroenterol Hepatol; 2016 Aug; 31(8):1429-35. PubMed ID: 26824898
[TBL] [Abstract][Full Text] [Related]
15. Upregulated expression of long non-coding RNA LINC00982 regulates cell proliferation and its clinical relevance in patients with gastric cancer.
Fei ZH; Yu XJ; Zhou M; Su HF; Zheng Z; Xie CY
Tumour Biol; 2016 Feb; 37(2):1983-93. PubMed ID: 26334618
[TBL] [Abstract][Full Text] [Related]
16. MiR-96-5p inhibition induces cell apoptosis in gastric adenocarcinoma.
Zhou HY; Wu CQ; Bi EX
World J Gastroenterol; 2019 Dec; 25(47):6823-6834. PubMed ID: 31885423
[TBL] [Abstract][Full Text] [Related]
17. Reduced miR-485-5p expression predicts poor prognosis in patients with gastric cancer.
Jing LL; Mo XM
Eur Rev Med Pharmacol Sci; 2016 Apr; 20(8):1516-20. PubMed ID: 27160123
[TBL] [Abstract][Full Text] [Related]
18. miR-215 promotes malignant progression of gastric cancer by targeting RUNX1.
Li N; Zhang QY; Zou JL; Li ZW; Tian TT; Dong B; Liu XJ; Ge S; Zhu Y; Gao J; Shen L
Oncotarget; 2016 Jan; 7(4):4817-28. PubMed ID: 26716895
[TBL] [Abstract][Full Text] [Related]
19. miR-130a acts as a potential diagnostic biomarker and promotes gastric cancer migration, invasion and proliferation by targeting RUNX3.
Jiang H; Yu WW; Wang LL; Peng Y
Oncol Rep; 2015 Sep; 34(3):1153-61. PubMed ID: 26134263
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-1225-5p inhibits proliferation and metastasis of gastric carcinoma through repressing insulin receptor substrate-1 and activation of β-catenin signaling.
Zheng H; Zhang F; Lin X; Huang C; Zhang Y; Li Y; Lin J; Chen W; Lin X
Oncotarget; 2016 Jan; 7(4):4647-63. PubMed ID: 26684358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
